Albendazole Market

Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.

Albendazole Market contains market size and forecasts of Albendazole in global, including the following market information:

Global Albendazole Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Albendazole Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Albendazole companies in 2021 (%)

The global Albendazole market was valued at 163.7 million in 2021 and is projected to reach US$ 271 million by 2028, at a CAGR of 7.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Albendazole include GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd and Supharma Chem and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Albendazole manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Albendazole Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Albendazole Market Segment Percentages, by Type, 2021 (%)

Tablet

Capsule

Other

Global Albendazole Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Albendazole Market Segment Percentages, by Application, 2021 (%)

Human

Veterinary

Global Albendazole Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Albendazole Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Albendazole revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Albendazole revenues share in global market, 2021 (%)

Key companies Albendazole sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Albendazole sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GlaxoSmithKline

Huazhong Pharmaceutical

Jiangsu Qihui

Sequent Scientific

K.A. Malle Pharmaceuticals

Lasa Supergenerics Limited

Zhongjia Pharmaceutical

Fredun Pharmaceuticals Ltd

Supharma Chem

Salius Pharma